METHOD FOR ENHANCING REMYELINATION VIA CO-ADMINISTRATION OF MUSCARINIC RECEPTOR ANTAGONISTS AND VITAMIN D ANALOGUES

METHOD FOR ENHANCING REMYELINATION VIA CO-ADMINISTRATION OF MUSCARINIC RECEPTOR ANTAGONISTS AND VITAMIN D ANALOGUES

Disclosed herein are methods and compositions for treating a demyelinating disease, such as multiple sclerosis, by administering to a subject suffering the disease a combination of at least one muscarinic receptor antagonist and at least one vitamin D receptor agonist. L'invention concerne des...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: ELIASOF, Scott, BEYER, Brittney A, LAIRSON, Luke L, TAIT, Bradley D
Format: Patent
Sprache:eng ; fre
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Disclosed herein are methods and compositions for treating a demyelinating disease, such as multiple sclerosis, by administering to a subject suffering the disease a combination of at least one muscarinic receptor antagonist and at least one vitamin D receptor agonist. L'invention concerne des méthodes et des compositions pour traiter une maladie démyélinisante, telle que la sclérose en plaques, par administration à un sujet atteint de la maladie d'une combinaison d'au moins un antagoniste du récepteur muscarinique et d'au moins un agoniste du récepteur de la vitamine D.